Chloramphenicol, tetracycline, erythromycin, rifampin, sulfonamides, penicillins, and aminoglycosides have been tested for antirickettsial activity in in vitro systems and animal models of disease (1, 3, 4, 6) . As far as we know, no one has evaluated ciprofloxacin in an animal model of rickettsial disease in a controlled fashion. We performed such an experiment and found ciprofloxacin as effective as chloramphenicol in our model. Rickettsia tsutsugamushi Karp which had been stored at -70°C was grown in embryonated egg. It was harvested in Snyder buffer and diluted in cold brain heart infusion broth to a dilution of 1,000 mouse 50% lethal doses as determined by titration in mice. It was stored on ice until inoculation. We used chloramphenicol succinate (Parke, Davis, & Co., Morris Plains, N.J.), gentamicin (Schering Corp., Kenilworth, N.J.), and ciprofloxacin (Miles Corp., West Haven, Conn.). A pilot study was performed in which uninfected mice received the experimental dosages of all antibiotics to determine if there was any mortality inherent in our antibiotic regimens. No mortality due to antibiotic was observed during the experimental interval. Chloramphenicol was administered at 300 mg/kg of body weight per day, gentamicin was administered at 30 mg/kg per day, and ciprofloxacin was administered at 120 mg/kg per day. These dosages represent six times the adult human dosage. Drugs were given by intraperitoneal injection in three divided doses per day to female BALB/cj mice. Control animals received normal saline. The various antibiotics were formulated to be administered in identical volumes of 0.50 ml. Animals were injected with rickettsiae on day 1 of the experiment and received antibiotic treatment from day 6 through day 10. Animals were observed until death or day 24, at which point they were sacrificed. Survival was determined on a daily basis. Each group (17 mice each) received one of the antibiotics, and a group of 15 mice received the saline control. On day 4 of the experiment, immediately prior to administration of dose 11 of antibiotic, two randomly selected animals were sacrificed for determination of antibiotic levels. Antibiotic levels were determined by bioassay with dilutions of antibiotics in mouse serum to establish the standard regressions. At the end of the experiment, the surviving animals were sacrificed and enzyme-linked immunosorbent assay titers for total immunoglobulin were determined to discover if seroconversion to R. tsutsugamushi had occurred.
The results of the experiment showed that all 15 animals treated with gentamicin or saline died and all 15 of the animals treated with ciprofloxacin or chloramphenicol lived. The average length of survival for the gentamicin-and placebo-treated mice was 9 days. Using the Fisher exact test as a method of statistical analysis, we compared survival in each antibiotic group to survival in the saline control group. The difference in survival between placebo-treated and ciprofloxacin-or chloramphenicol-treated mice was highly significant (P < 0.01). Assays performed on pooled mouse sera from the mice sacrificed prior to the end of the experiment yielded trough concentrations of gentamicin that were less than 1 ,ug/ml, of ciprofloxacin that were 2 p.g/ml, and of chloramphenicol that were less than 30 ,ug/ml, the lowest concentration studied. All of the surviving animals had titers to R. tsutsugamushi that were over 1:320, which is indicative of an infection survived.
We administered 1,000 times the 50% lethal dose of R. tsutsugamushi to the experimental animals. This high inoculum was used both to eliminate the variability of onset in symptoms which occurred with lower doses of R. tsutsugamushi and because it is a standard inoculum for evaluating the efficacy of vaccines in one of our laboratories. At this dose of R. tsutsugamushi, mice regularly developed symptoms by day 8 postinoculation. They were usually dead by day 14 postinoculation. We chose to perform an animal experiment because of the lack of established correlation between in vitro and in vivo models. We knew because of the ratio of surface area to volume that drugs would be cleared more rapidly in the mouse than in a larger animal, so we determined in a pilot study an effective dosage which was a multiple of the normal human dosage of drugs.
There is precedent for the effectiveness of quinolones in this type of infection. Nalidixic acid was tested in vitro and found to be inhibitory for chlamydiae (5) . Raoult administered ciprofloxacin clinically to five patients with Mediterranean spotted fever and felt that ciprofloxacin improved their course of illness (2). 
